Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Additional information

Short description of key information:
For anthracene oil containing less than 50 ppm of BaP (structure-related to anthracene paste), weakly mutagenic potential may be observed in vitro:
An Ames test in the presence of metabolising enzymes was positive only in TA 100 at cytotoxic concentrations;
A mouse-lymphoma assay (MLA, OECD 476) was weakly positive for the closely structure-related tar oil creosote;
A cytogenetic assay (chromosomal aberration, OECD 473) came out negative for the very same tar oil.
An in-vivo micronucleus test in mice using creosote gave no evidence of a mutagenic potential.

Endpoint Conclusion: No adverse effect observed (negative)

Justification for classification or non-classification

The slight mutagenic potential eventually detected in in-vitro standard assays conducted with structure-related tar oils containing BaP levels of =< 50 ppm has not been confirmed in an in vivo mammalian erythrocyte micronucleus assay.

Taking into account the combined evidence of all the tests performed, the overall mutagenicity potential should be evaluated negative. Annthracene paste (BaP =< 50 ppm) is supposed to reflect similar mutagenic properties.

Thus, classification according to Regulation (EC) No 1272/2008 or Directive (EU) 67/548/EEC is not required.